Nature's Sunshine (NATR) Q2 Earnings Report Preview: What To Look For
Nature’s Sunshine (NATR) will report Q2 earnings Thursday after the bell. The company previously reported Q1 revenue of $122.9M, up 8.5% YoY, and beat analysts on EPS and EBITDA. For Q2, analysts expect revenue up 7.8% YoY. The article cites an average analyst price target of $34.50 vs a $20.45 share price.
How this was made

The 30-second read
Why it matters
The main tradable element is the earnings timing plus consensus revenue growth and the stock’s relative underperformance versus the personal care segment, which can influence expectations and positioning into the print.
Market read
This preview frames what to watch in NATR’s upcoming earnings, using consensus growth, prior-quarter performance, and peer read-across.
What to watch
No guidance, margin drivers, or product/order details are provided, so traders may be underestimating the risk that the market focuses on profitability or forward commentary rather than revenue growth.
Background
Nature’s Sunshine is previewed ahead of its Q2 earnings release after the bell on Thursday, following a prior-quarter revenue and EPS/EBITDA beat.
Ticker impact
Nature’s Sunshine is set to report Q2 earnings after the bell, with the article citing revenue growth expectations and recent estimate reconfirmations.
Near-term volatility is likely around the after-hours earnings print, with upside/downside driven by whether revenue growth and margins/EBITDA align with expectations.
The article provides consensus growth (7.8% YoY) and notes prior-quarter beats, but it does not disclose any new company-specific development beyond the upcoming earnings timing and estimate context.
Market effects
Personal care peers’ mixed Q2 results (Medifast down YoY, USANA down YoY) may shape read-across expectations for NATR’s margin and demand signals.
None stated.
None stated.
Counterpoint
Because the article stresses that NATR “rarely misses” revenue estimates, the market may instead trade the earnings quality (EBITDA/margins) rather than the top-line beat.
Key entities
- companyNature’s Sunshine
NASDAQ-listed wellness products company scheduled to report Q2 earnings after the bell Thursday.
- companyMedifast
Personal care peer referenced for its Q2 revenue decline and post-results stock reaction.
- companyUSANA
Personal care peer referenced for its Q2 revenue decline and miss versus expectations.


